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Abstract
The inhibition of specific SH2 domain mediated protein-protein interactions as an effective chemotherapeutic approach in
the treatment of diseases remains a challenge. That different conformations of peptide-ligands are preferred by different
SH2 domains is an underappreciated observation from the structural analysis of phosphotyrosine peptide binding to SH2
domains that may aid in future drug design. To explore the nature of ligand binding, we use simulated annealing (SA) to
sample the conformational space of phosphotyrosine-containing peptides complexed with the Src SH2 domain. While in
good agreement with the crystallographic and NMR studies of high-affinity phosphopeptide-SH2 domain complexes, the
results suggest that the structural basis for phopsphopeptide- Src SH2 interactions is more complex than the ‘‘two-pronged
plug two-hole socket’’ model. A systematic study of peptides of type pYEEX, where pY is phosphotyrosine and X is a
hydrophobic residue, indicates that these peptides can assume two conformations, one extended and one helical,
representing the balance between the interaction of residue X with the hydrophobic hole on the surface of the Src SH2
domain, and its contribution to the inherent tendency of the two glutamic acids to form an a-helix. In contrast, a b-turn
conformation, almost identical to that observed in the crystal structure of pYVNV bound to the Grb2 SH2 domain,
predominates for pYXNX peptides, even in the presence of isoleucine at the third position. While peptide binding affinities,
as measured by fluorescence polarization, correlate with the relative proportion of extended peptide conformation, these
results suggest a model where all three residues C-terminal to the phosphotyrosine determine the conformation of the
bound phosphopeptide. The information obtained in this work can be used in the design of specific SH2 domain inhibitors.
Citation: Nachman J, Gish G, Virag C, Pawson T, Pome `s R, et al. (2010) Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2
Domain. PLoS ONE 5(6): e11215. doi:10.1371/journal.pone.0011215
Editor: Bostjan Kobe, University of Queensland, Australia
Received March 9, 2010; Accepted May 25, 2010; Published June 21, 2010
Copyright:  2010 Nachman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by a grant from PrioNet, National Centre of Excellence, Canada, and the Canada Research Chairs Program. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nachman@hera.med.utoronto.ca
Introduction
SH2 (Src homology 2) domains are found as modules in many
proteins involved in cell signal transduction pathways. They bind
to short stretches of amino acids that contain phosphorylated
tyrosine residues (pTyr) and thereby mediate the interactions
between proteins during cell signaling. Since these processes
control cell growth and differentiation, abnormal alterations of
these signaling pathways result in malignancies. For example, the
Src family of tyrosine kinases, whose members contain SH2
domains, play a role in both breast cancer [1] and osteoporosis
[2,3]. Their SH2 domains bind to pTyr-containing proteins, such
as middle T antigen and various growth factor receptors [1,4], and
are therefore considered attractive targets for developing small-
molecule inhibitors that would selectively disrupt these signaling
processes. However, development of efficient small-molecule
inhibitors has proven difficult, suggesting that a better under-
standing of the structural basis underlying phosphopeptide-SH2
domain interactions is required. To this end we have undertaken a
computational and experimental study to systematically evaluate
the role residues C-terminal to the pTyr anchor may play in the
binding affinity and conformation of phosphopeptides when
bound to the Src SH2 domain.
The Src SH2 domain binds with high affinity pTyr-Glu-Glu-Ile
(pYEEI) [5]. The crystal [6,7] and NMR [8] structures of this
complex reveal that pYEEI adopts an extended conformation and
that it forms its main interactions with the SH2 domain through
the phosphorylated tyrosine residue, which binds into a positively
charged pocket formed by two arginines (ArgaA2 and ArgbB5),
and the isoleucine at the third position C-terminal to pTyr
(pTyr+3), which binds into a hydrophobic pocket formed by the
EF and FB loops (Figure 1). The contribution by the residue at
position pTyr+3 has been demonstrated by the fact that
substitution of smaller hydrophobic residues at this position results
in decrease of binding affinity [9]. Based on these findings, the
‘‘two-pronged plug two-holed socket’’ model has been proposed,
which postulates that binding of phosphopeptides to the Src SH2
domain is determined by phosphotyrosine and the hydrophobic
residue at position pY+3. However, binding studies of conforma-
tionally constrained peptide analogs of pYEEI show that they have
higher binding affinities than the unconstrained pYEEI [10,11],
suggesting that the ‘‘two-pronged plug two-holed socket’’ model
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11215may be an oversimplification and that any binding model must
take into account the inherent flexibility of short peptides.
Since neither single-crystal X-ray diffraction methods, nor
NMR methods have yielded a complete picture of the conforma-
tional diversity of phosphopeptides complexed with SH2 domains,
we have turned to computational methods to explore the
conformational trends of the bound phosphopeptides. Molecular
simulations are well suited for this purpose; however, exhaustive
sampling of the conformational space of even small peptides using
fully solvated models, whether by Monte-Carlo methods or by
molecular dynamics, is computationally expensive. A widely used
computationally-efficient approach to this problem is simulated
annealing, which is based on high-temperature sampling of
selected degrees of freedom in implicit solvent [12–16].
Using this simulated annealing method in combination with
fluorescence polarization techniques, we explore the conforma-
tional space of various phosphopeptides bound to the Src SH2
domain. We characterize the conformational landscape of the
bound peptides by systematically examining the effect of different
cooling rates, and we identify their conformational trends. We
show that the nature of the residue at pTyr+3 plays an important,
but not the key role in determining the binding affinity and the
conformation of the bound peptide.
Methods
Phosphopeptide Assays
The relative binding affinity of phosphopeptides to the Src SH2
domain was tested by competition against a fluorescent probe
using a fluorescence polarization (FP) binding assay [11,17,18]. FP
was measured at 25uC in a disposable glass tube, using a Beacon
2000 luminescence spectrometer equipped with an FP apparatus.
The excitation and emission wavelengths were set at 485 and
535 nm, respectively. The fluorescent probe was the fluorescein
(Flc)-labeled phosphopeptide EPQ(pY)EEIPIYL(K-Flc). For the
competition assay, final concentrations of 350 nM of GST-Src
SH2 domain fusion protein, 50 nM fluorescent probe, HEPES
buffer (20 mM, pH 7.3, 100 mM NaCl, 2 mM DTT, 0.1% BSA)
and various concentrations (0–100 mM) of each competitor
peptide were used. A blank control (with the Src SH2 domain
but without a peptide) and a background control (without both the
Src SH2 domain and the peptide) were used. The inhibition
percentage IP of fluorescent probe binding to the Src SH2 domain
by the sample was calculated by the following equation:
IP~100|
FP0{FP
FP0{FPb
where FP0 is the fluorescent polarization value of the blank
control, FP is the fluorescent polarization value of the sample
(peptide), and FPb is the fluorescent polarization value of the
background control. The inhibition percentages of the various
concentrations of the assayed peptides were plotted, and the IC50
value (the concentration that inhibits the binding of the fluorescent
probe to the Src SH2 domain by 50%) was calculated.
Molecular Dynamics Simulations
Sampling of the conformational space of the phosphopeptides
complexed with the Src SH2 domain was carried out using a
simulated annealing procedure in which a number of conforma-
tionally random replicas of the bound peptide are generated at
high temperature, and then slowly cooled down. The conforma-
tion of the SH2 domain is assumed to remain unchanged; this
Figure 1. The Src SH2 domain complexed with pYEEI. (A) Cartoon representation of the complex. Residues ArgaA2 and ArgbB5 of the SH2
domain are in blue, residue Ile(pY+3) of the phosphopeptide is in magenta. (B) Electrostatic surface potential representation of the same complex.
The phosphotyrosine sits in a highly electropositive hole, while residue Ile(pY+3) is inserted into the hydrophobic hole on the surface of the SH2
domain.
doi:10.1371/journal.pone.0011215.g001
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both free and peptide-bound SH2 domains, which show that their
structure is not affected by binding [6,19]. At the end of the
cooling process the main conformations present in a given replica
population are identified by performing cluster analysis.
All molecular dynamics simulations were performed using the
Sander-classic module in the AMBER6 package [20] with the ff96
force field together with Verlet dynamics. (A basic description of
the methods incorporated in AMBER is given elsewhere [21].)
The starting models for the simulated annealing procedure are
either crystal structures of phosphopeptide-SH2 domain complex-
es, or – where such structures are not available – models built by
mutating phosphopeptide residues from a closely related crystal
structure. In both cases energy minimization preceded the start of
the SA process.
The simulations were performed in a finite size, non-periodic
system. Since exhaustive sampling of the full conformational space
is beyond the reach of explicit-solvent simulations, the solvent
effect is represented by a distance-dependent dielectric constant of
the form e=R ij (where Rij is the distance between particles i and j)
[22]. Non-bonded interactions were calculated using a 12.0 A ˚ cut-
off radius. In order to prevent the SH2 domain from unfolding at
high temperature, only the peptide residues C-terminal to the
phosphotyrosine were allowed to move freely; harmonic restraints
of 25 kcal/(mol*A ˚ 2) were applied to phosphotyrosine atoms, while
the SH2 domain atoms were constrained to their positions in the
starting models.
Partial charges for the phosphotyrosine were derived using the
restrained electrostatic potential method (RESP) [23]; the ESP
(electrostatic potential) input for RESP was generated using the
package GAUSSIAN96 [24] with the 6-31G basis set [25]. The
force field parameters of the phophotyrosine is supplied as Text
S1. Since a distance-dependent dielectric does not screen
electrostatic interactions between charged groups sufficiently well
[26], all net charges were neutralized by using the protonated
forms of Asp and Glu, and neutral forms of Lys and Arg, except
for the peptide’s phosophotyrosine and the for the SH2 domain
residues ArgaA2 and ArgbB5, which form salt bridges to the
phosphotyrosine (Figure 1); the N- and C-termini were neutr-
alized by attaching acetyl (ACE) and N-methylamine (NME),
respectively.
Before starting the SA protocol, the geometries of the starting
models were optimized and bad interatomic contacts relieved by
energy minimization consisting of 250 steps of steepest descent,
followed by 750 steps of conjugate gradient minimization.
Following the initial energy minimization, the SH2 domain
complexed with the phosphotyrosine containing peptide was
heated up to 3000K over three 10 ps long temperature steps, after
which 50 samples were collected at this temperature at regular
time intervals, varying between 2.5 and 10 ps. The time intervals
were chosen so as to maximize both the conformational spread of
the 50 copies, and their average CA-RMSD with respect to the
starting model. Each structure was then cooled down using a
logarithmic cooling protocol: at each cooling step i, the
temperature T was chosen such that:
T(i)~xT(i{1), where 0vxv1
with x set to 0.8.
In order to characterize the energy landscape of the bound
peptide, we tested various cooling rates, ranging from 10ps to
500ps per temperature step. This allowed us to identify structural
trends of the peptide bound to the SH2 domain, as well as the rate
at which these trends evolve, yielding a qualitative picture of the
energy landscape.
The copies were cooled down to 300K, after which they
underwent another round of energy minimization consisting of
200 steepest descent steps and 600 conjugate gradient steps. After
all copies were cooled down and energy minimized, their CA-
RMSDs from the initial structure were calculated and cluster
analysis was performed by examining the joint rmsd-energy
distribution, as well as using NMRCLUST (based on pair-wise
RMSD) [27].
Results
Binding Affinities of Phosphopeptides
The IP50 of various phosphopeptides are presented in Table 1.
The binding affinities of the various phosphopeptides to the Src
SH2 domain only vary by one order of magnitude. The complexes
of Src SH2 with peptides of type pYEEX (where X=I,L,V,A,G)
have binding affinities correlated with the size of the residue at
position pTyr+3, but the differences between the binding affinities
are modest, as is also observed in calorimetric studes [9]. The
contributions of the two glutamic acids at positions pTyr+1 and
pTyr+2 to the binding affinity can be assessed by comparing the
changes in IC50 effected by mutating these two residues, with the
changes resulting from mutations of the residue at position
pTyr+3. Substitution of Glu(pTyr+2) with Asn in pYEEI and
pYEEV (to yield pYENI and pYENV, respectively), or of
Ile(pTyr+3) with Val in pYEEI and pYENI causes a decrease in
binding affinity by approximately 1.8 kJ/mol. Furthermore,
replacing Glu(pTyr+1) with Val in pYENV causes a 3.3 kJ/mol
decrease.
pTyr-Glu-Glu-Ile-Pro
The starting model for this simulation was the crystal structure
of the high-affinity (0.08–0.2 mM) [9,28] complex of Src SH2 with
pTyr-Glu-Glu-Ile-Pro (PDB code: 1SPS) [6]. The 50 structures
generated at 3000K have an average CA-RMSD of 662A ˚ from
the starting model, with values ranging between 2 and 12 A ˚, and
68% of the structures with RMSDs larger than 5 A ˚. The average
potential energy is 2280613 kcal/mol, with values between
2316 and 2251 kcal/mol.
SA dynamics of this complex with various cooling schedules,
which differ from each other by the time spent at each
Table 1. Relative binding affinity of various phosphopeptides
with the Src SH2 domain.
IC50 (mM) est. DG (kJ/mol)
pYEEI 0.560.2 235.9
pYEEL 0.860.3 235.2
pYEEV 1.160.1 234.0
pYEEA 5.062.2 230.2
pYEEG 5.762.1 229.9
pYENI 1.060.1 234.2
pYENV 2.160.7 232.4
pYVNV 7.962.0 229.1
IC50: concentration that reduces the binding of the fluorescein-labeled probe
EPQ(pY)EEIPIYL(K-Flc) to the Src SH2 domain by 50%.
doi:10.1371/journal.pone.0011215.t001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11215Figure 2. Spatial and energy distribution of the SA replicas of pYEEI and pYVPM complexed with Src SH2. (A and D) after energy
minimization at 3000K; (B and E) after cooling with 50ps per temperature step; (C and F) after cooling with 500ps per temperature step.
doi:10.1371/journal.pone.0011215.g002
Figure 3. Conformational trends of pYEEI and pYVPM complexed with the Src SH2 domain. Backbone representation of the 50
computational replicas of pYEEI (A–C) and of pYVPM (D–F) superimposed on the crystal structures of these phosphopeptides in complex with the Src
SH2 domain. (A and D) after energy minimization at 3000K; (B and E) after cooling with 500ps per temperature step. The backbone of the SH2 domain
is in black, the SA replicas are in red. (C and F) Phosphopeptide backbone of the representative structure of the largest cluster after cooling with
500ps per temperature step, with side-chains of pTyr and of residue in position pTyr+3 (in red). The backbone of the crystal structure of the
phosphopeptides and the side chains of the pTyr and residue pTyr+3 is in green. The SH2 domain is represented as an electrostatic potential surface.
The representative structure of a cluster is the structure closest to the average structure of the cluster.
doi:10.1371/journal.pone.0011215.g003
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schedules, most of the structures cluster close to the starting model.
Cooling with 50 ps per temperature step results in an average
CA-RMSD of 462A ˚ relative to the starting model and the
average energy is 233567 kcal/mol. At 500 ps per cooling step,
the average CA-RMSD is 362A ˚ and the average energy is
234263 kcal/mol. When considering only the three residues that
form the specificity determining segment: Glu(pTyr+1)-Glu(p-
Tyr+2)-Ile(pTyr+3), the average RMSD goes from 562A ˚ at
3000K (Figure 2A and 3A) to 362A ˚ after cooling at a rate of
50 ps/step, to 261A ˚ at 500ps/step, with 72% of the population
(36 replicas out of 50) in a cluster with an average CA-RMSD of
160.5 A ˚ (Figure 2B–C and 3B). Most of the structures in this
cluster have the side chain of Ile(pTyr+3) inserted in the
hydrophobic hole lined by residue ThrEF1 of the Src SH2
domain (Figure 3C). The remaining 14 copies have CA-RMSDs
between 3 A ˚ and 5 A ˚, with 8 of them in a tight cluster around 4 A ˚
from the extended conformation, forming a distorted helix turn.
pTyr-Val-Pro-Met-Leu
This complex is less specific, with a reported Kd of 5.5 mM [9].
In the crystal structure (PDB code: 1SHA) the phosphopeptide
assumes a slightly bent extended conformation, with Met(pTyr+3)
partially inserted in the hydrophobic pocket [29].
After cooling at a rate of 500 ps/step, the average CA-RMSD
of the 50 copies of pYVPML relative to the crystal structure
decreases from 662A ˚ to 362A ˚, with 56% of the population in a
cluster with a CA-RMSD of 1.560.5 A ˚. The CA-RMSD of the
specificity determining segment Val(pTyr+1)-Pro(pTyr+2)-Met(p-
Tyr+3) goes from 4.061A ˚ at 3000K, to 361A ˚ with a cooling
rate of 50 ps/step, to 261A ˚ at 500 ps/step; 94% of the
population lie in a broad cluster with an average CA-RMSD of
261A ˚, and 28% of the population in a tight sub-cluster with a
CA-RMSD of 0.660.1 A ˚ (Figure 2D–F and 3D–F).
The pTyr-Glu-Glu-(Hydrophobic) series
For the complexes of Src SH2 with peptides of type pYEEX
(where X=I,L,V,A,G) the binding affinities correlated with the
size of the residue at position pTyr+3 (Table 1). Since with the
exception of pYEEI, no crystal structures are available for these
complexes the starting models for this simulations were built from
the crystal structure of the Src SH2-pYEEI complex (PDB code:
1SPS), in which the Ile(pTyr+3) was replaced by Leu, Val, Ala and
Gly, respectively.
For all five phosphopeptides, SA with 500ps/step results in 80%
of the population located in two clusters, indicating two main
tendencies for the phosphopeptide conformation (Figure 4). One
cluster is close to the extended conformation observed in the
pYEEI-Src SH2 complex (CA-RMSD=1–2 A ˚); the other cluster,
with CA-RMSD=4–5 A ˚ is close to a helical conformation
(Figures 4 and 5). As the size of the side chain of pTyr+3 residue
decreases, so does the population of the first cluster, and the
deviation from the extended conformation increases (CA-RMSD
of 1.5 A ˚ for pYEEL and pYEEV, and 2 A ˚ for pYEEA). The
population of the second cluster increases and its deviation from
the ideal helical conformation decreases. The extreme cases are
pYEEI and pYEEG, where more than 70% of the population is in
the extended and helical conformation, respectively. The deviation
from the extended conformation in the first cluster is caused by a
bend at residue +3 in the direction of the CD loop and away from
the hydrophobic pocket of the SH2 domain (Figure 5). A third,
very small cluster (comprising 6 to 12% of the population) with
CA-RMSD of 5 A ˚ from the extended conformation and 6 A ˚ from
the helical one can be observed in all five complexes; it
corresponds to a conformation in which Glu(pTyr+1) is rotated
by about 180u around the N-CA bond, resulting in the side chain
of Glu(pTyr+1) pointing towards the DE loop and in the main
chain of the peptide bending by almost 90u towards the CD loop.
pTyr-Glu-Asn-Ile and pTyr-Val-Asn-Val-Ala
These two peptides have lower binding affinities to Src SH2,
with IC50 of 1.0 mM for pYENI and 7.9 mM for pYVNV (Table 1).
pYVNV binds tightly to the Grb2 SH2 domain, as well as to a
mutant of Src SH2 where residue ThrEF1 is replaced by Trp [28].
In those complexes the peptide assumes a b-turn conformation
[19,30], with residue Asn(pTyr+2) forming hydrogen bonds with
Figure 4. Spatial distribution of Simulated Annealing replicas
of the pYEEX series between the extended and helical
conformation after cooling at 500ps per step. From top to
bottom: pYEEI, pYEEL, pYEEV, pYEEA, pYEEG.
doi:10.1371/journal.pone.0011215.g004
Conformational Determinants
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LysbD6 and the carbonyl of LysbD6 and IlebE4.
The starting model for the simulation of both pYENI and
pYVNV complexes was the crystal structure of the pYEEIP-Src
SH2 complex [6]; for pYENI, Glu(pTyr+2) was mutated to Asn,
whereas for pYVNV the three residues C-terminal to pTyr,
Glu(pTyr+1), Glu(pTyr+2) and Ile(pTyr+3), where mutated to
Val, Asn and Val, respectively.
In both complexes, SA results in major clusters with CA-
RMSDs of 4.0–4.5 A ˚ from the extended conformation (Figure 6),
which corresponds to the b-turn conformation observed in the
structure of pYVNV complexed with Grb2 SH2 or with the
ThrEF1Trp mutant of Src SH2 (Figure 7). In the case of pYVNV,
50% of the population is in the b-turn conformation, 25% of the
population forms a slightly broader cluster with a CA-RMSD of
2A ˚ from the extended conformation, and another 12% lie in a
cluster about 6 A ˚ from both the extended and the b-turn
conformation, corresponding to a conformation in which the
peptide forms a roughly 90u bend towards the CD loop. In the
pYENI complex, 60% of the population is in the b-turn
conformation and 30% in the extended conformation with
Ile(pTyr+3) inserted in the hydrophobic pocket of the SH2
domain, as observed in the high-affinity complex of pYEEI. In
both complexes, residue Asn(pTyr+2) forms the same polar
contacts with the main-chain amino and carbonyl groups observed
in the crystal structures of pYVNV complexed with the Grb2 SH2
domain or with the mutant ThrEF1Trp of the Src SH2 domain
(Figure 8).
Discussion
The results obtained using our simulated annealing protocol are
consistent with those obtained by other theoretical and experi-
mental studies. Specifically, the deviations from the extended
conformation observed in the SH2-bound peptides pYEEA and
pYEEG are similar to those reported in a more sophisticated,
parallel tempering dynamics study of Ala and Gly mutants of
pYEEI bound to Src SH2 with implicit solvent and a different
energy function [31]. Likewise, the conformation predicted by our
computational technique for the pYXN fragment of pYVNV and
pYENI complexed with Src SH2 agree with the one obtained
using a Monte Carlo search [32]. Most significantly, the
conformational trends identified by the simulated annealing
method for the pYEEI and pYVPM peptides bound with,
respectively, high and low affinity to the Src SH2 domain are in
very good agreement with the conformations observed in the
crystallographic structures of these complexes [6,29]. These results
show that in spite of its approximations, i.e.: use of implicit solvent,
neutralization of local charges, constraining the structure of the
SH2 domain, the simulated annealing approach, as implemented
in this work, yields reliable results in identifying the conforma-
Figure 5. Conformational trends of the pYEEX series of peptides complexed with the Src SH2 domain. (A) Cartoons of representative
structures of the ‘‘extended’’ conformation cluster of the pYEEX series superimposed on the structure of pYEEI complexed with the Src SH2 domain;
(B) Representative structures of the ‘‘helical’’ conformation cluster of pYEEX series, superimposed on an ideal helix. The reference conformations for
extended and helical clusters are in magenta, pYEEI, red, pYEEL, yellow, pYEEV, green, pYEEA blue, pYEEG, light blue.
doi:10.1371/journal.pone.0011215.g005
Figure 6. Spatial distribution of the replicas between extended
and b-turn conformation for pYVNV (black) and pYENI (red),
after cooling with 500ps per temperature step.
doi:10.1371/journal.pone.0011215.g006
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Using various cooling rates allowed us to monitor the rate at which
the population clusters are developing, which, in turn, is indicative
of the heterogeneity of the energy landscape for this system.
The results of the fluorescence polarization assays suggest that
the two glutamic acids at positions pTyr+1 and pTyr+2 provide a
significant contribution to the binding energy through their
electrostatic interactions with positively charged residues on
the surface of the Src SH2 domain, and that all three residues
C-terminal to the pTyr are equally important in determining the
binding affinity.
In all complexes with the Src SH2 domain, the fragments of
type pYEEX (X=I,L,V,A,G) adopt two main conformations: one
fully or partially extended, the other one partially helical. The
presence of a helical conformation for the pYEEX fragment is
entirely consistent with the strong helical propensity of Glu
residues [33,34]. As the size of the residue at position pTyr+3
decreases, the tendency towards the extended conformation
Figure 7. Conformational trends of the pYVNV and pYENI complexed with the Src SH2 domain. (left) Backbone representations of the 50
replicas (red) superimposed on the crystal structure of the pYVNV-ThrEF1Trp Src SH2 domain complex and the modeled extended conformation of
pYVNV for (A) pYVNV and (C) pYENI. (right) Backbone of the representative structure of the main cluster (red) and minor cluster (pink) with the side-
chain of residue Asn(pTyr+2) for (B) pYVNV and (D) pYENI. Backbone of SH2 domain in black, modeled extended conformation of pYVNV in yellow, b-
turn conformation of pYVNV in blue.
doi:10.1371/journal.pone.0011215.g007
Conformational Determinants
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conformation increases. However, the correlation between the
size of residue pTyr+3 and the structural trends displayed by the
corresponding phosphopeptide is not straightforward: as one can
see in Figure 4, in the case of both pYEEL and pYEEV the
populations of the extended and helical conformations are very
close (50% and 40% of the population, respectively), even though
Val is smaller than Leu. This can be explained by the fact that
while Leu is a very strong helix former, it also interacts strongly
with the hydrophobic hole of the Src SH2 domain, whereas Val
has only weak helical propensity, but interacts only weakly with
the hydrophobic hole; in both cases, therefore, the two opposing
tendencies balance each other, resulting in roughly equal
populations. At the same time, the structural trends of pYEEL
and pYEEI are strikingly different, even though Leu and Ile are
very close in size: in the case of pYEEI 72% of the population is in
the extended conformation and only 16% adopts the helical
conformation. This, too, can be explained by the difference in
helical propensities between Leu and Ile: while both amino-acids
interact in a similar manner with the Src SH2 hydrophobic hole,
Ile has a much weaker helical propensity than Leu. Therefore, the
conformation of the pYEEX fragment in the complex with the Src
SH2 domain appears to be the result of the competition between
the additional contribution of residue pTyr+3 to the helical
propensity of the two glutamic acid residues at the first and second
position after the phosphotyrosine, on the one hand, and its
interaction with the hydrophobic hole of Src SH2 domain, on the
other hand.
The fact that when pYVNV is bound to the Src SH2 domain, it
adopts mainly a b-turn conformation with Asn(pTyr+2) forming
non-specific polar contacts with the protein, confirms the
prediction that in addition to pYEEI the Src SH2 domain is also
capable of binding peptides of the type pYXNX [32]. According
to this prediction, these peptides should assume a b-turn
conformation, except in the case when the residue at position
pTyr+3 engage in strong interactions with the hydrophobic hole
on the surface of the Src SH2 domain. Therefore, one would
expect the pYENI fragment to adopt mainly the extended
conformation, because of the presence of Ile at position pTyr+3.
However, the population of the b-turn conformation of pYENI
bound to Src SH2 is higher than that of the extended
conformation. This suggests that the presence of Asn at position
Figure 8. Hydrogen bonds formed by Asn(pY+2) in pYVNV and pYENI complexed with SH2 domains. (A) pYVNV complexed with the
ThrEF1Trp mutant of Src SH2; (B) pYVNV complexed with wt Src SH2 (representative of the major cluster); (C) pYENI complexed with wt Src SH2
(representative of the major cluster). The phosphopeptide backbone is represented as a cartoon.
doi:10.1371/journal.pone.0011215.g008
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pTyr+3 as both an affinity and structure determinant.
In conclusion, we show that all three residues C-terminal to the
phosphotyrosine play an important role in determining both the
binding affinity of phosphopeptides complexed with the Src SH2
domain, as well as their conformation. Significantly, the
conformational trends of the bound phosphopeptides are a result
not only of the phosphopeptide-SH2 domain interactions, but also
of the intra-phosphopeptide interactions. These observations can
support the design of better, more specific inhibitors of the Src
SH2 domain.
Supporting Information
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